Technology
Health
Biotechnology

Arbutus Biopharma

$1.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-2.12%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ABUS and other stocks, options, ETFs, and crypto commission-free!

About ABUS

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.

Employees
80
Headquarters
Burnaby, British Columbia
Founded
2005
Market Cap
106.32M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
364.16K
High Today
$1.93
Low Today
$1.80
Open Price
$1.89
Volume
163.98K
52 Week High
$12.60
52 Week Low
$1.42

Collections

Technology
Health
Biotechnology
2015 IPO
Canada
North America

ABUS News

Yahoo FinanceJun 21

Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up

223

ABUS Earnings

-$0.47
-$0.41
-$0.36
-$0.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours

More ABUS News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.